Crossmark

Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren’s disease—a randomized controlled trial (DupuyShock)

Crossref DOI link: https://doi.org/10.1007/s10103-021-03254-9

Published Online: 2021-01-23

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Knobloch, Karsten http://orcid.org/0000-0003-1468-4258
Hellweg, Marie

Sorg, Heiko

Nedelka, Tomas
License Information

Text and Data Mining valid from 2021-01-23

Version of Record valid from 2021-01-23
More Information

Article History

Received: 18 June 2020

Accepted: 14 January 2021

First Online: 23 January 2021

Declarations

:

: The DupuyShock RCT received IRB approval by Hannover Medical School. It is registered in ExternalRef removed with the NCT number <b><i>NCT01184586.</i></b>

: MK, HS, and TN have nothing to declare. KK received honoraries for lectures for Storz Medical AG after completion of the trial, which do not have any impact on the results presented herein.

Document is current

Any future updates will be listed below